神州细胞公告，股东南昌神州安元企业管理咨询合伙企业(有限合伙)、南昌神州安恒企业管理咨询合伙 企业(有限合伙)、安义神州安隆企业管理咨询合伙企业(有限合伙)、安义神州安成企业管理咨询合伙企 业(有限合伙)、安义神州安乾企业管理咨询合伙企业(有限合伙)和安义神州安弘企业管理咨询合伙企业 (有限合伙)因个人资金需求，于2025年6月30日至2025年7月2日通过集中竞价交易方式合计减持公司股 份185.79万股，占公司总股本的0.42%，减持价格区间为59.21～63.88元/股。本次减持计划已实施完 毕。减持后，神州安元、神州安恒、神州安隆、神州安成、神州安乾及神州安弘合计持有的公司股份数 量由3650万股减少至3464.21万股，占公司总股本比例由8.20%减少至7.78%。 ...

[Table_Main] 行业研究|医疗保健 证券研究报告 本周神州细胞、浩欧博和华人健康等表现较好 涨幅排名前十的个股分别为：神州细胞（+30.45%）、浩欧博 （+27.08%）、华人健康（+26.00%）、华强科技（+22.94%）、迈威生 物（+17.44%）、南模生物（+16.51%）、锦好医疗（+16.05%）、百普 赛斯（+15.79%）、塞力医疗（+14.49%）、贵州百灵（+12.80%）。 跌幅排名前十的个股分别为：易明医药（-21.91%）、福元医药（- 11.50%）、博瑞医药（-9.36%）、悦康药业（-7.74%）、*ST 赛隆（- 6.87%）、众生药业（-6.04%）、常山药业（-5.93%）、科兴制药（-5.77%）、 圣诺生物（-5.12%）、赛升药业（-4.73%）。 医疗保健行业周报 2025 年 07 月 01 日 [Table_Title] 《2025 年基本医保目录及商保创新药目录调 整申报操作指南》出炉，继续看好创新药 ——医药生物行业周报（2025.6.23-2025.6.27） [Table_Summary] 报告要点： 医药板块本周跑输沪深 300 指数 ...

证券代码：688520 证券简称：神州细胞 公告编号：2025-034 北京神州细胞生物技术集团股份公司 自愿披露关于控股子公司产品 SCTB39G 获得 药物临床试验批准通知书的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 近日，北京神州细胞生物技术集团股份公司控股子公司神州细胞工程有限公 司（以下简称"公司"）收到国家药品监督管理局（以下简称"国家药监局"）核 准签发的《药物临床试验批准通知书》，同意公司自主研发的产品 SCTB39G 注 射液单药在晚期实体瘤患者中开展临床试验。由于药物临床试验过程中不可预测 因素较多，临床试验、审评和审批的结果以及时间都具有一定的不确定性，敬请 广大投资者谨慎决策，注意防范投资风险。 1. 产品名称：SCTB39G 注射液 2. 受理号：CXSL2500307 审批结论：根据《中华人民共和国药品管理法》及有关规定，经审查，申请 人提交的 SCTB39G 注射液临床试验申请符合药品注册的有关要求，同意本品单 药在晚期实体瘤患者中开展临床试验。 二、产品其他相关情 ...

神州细胞公告，控股子公司神州细胞工程有限公司收到国家药监局核准签发的《药物临床试验批准通知 书》，同意公司自主研发的产品SCTB39G注射液单药在晚期实体瘤患者中开展临床试验。SCTB39G为 多靶点免疫治疗三特异性抗体注射液。药物临床试验过程中不可预测因素较多，临床试验、审评和审批 的结果以及时间都具有一定的不确定性。 ...

Group 1 - The U.S. President Trump announced that Israel and Iran have agreed to a comprehensive ceasefire, which will begin approximately six hours after the announcement [2] - The ceasefire agreement includes two 12-hour ceasefire periods, with Iran initiating the first period and Israel following with the second [2] - Israeli Prime Minister Netanyahu requested cabinet members to refrain from commenting on the ceasefire until further notice [3] Group 2 - An Iranian official described Trump's ceasefire statement as a "provocation" against Iran [4] - U.S. stock markets saw a significant rise, with the S&P 500 recovering to 6025.17 points, driven by expectations of a potential interest rate cut by the Federal Reserve [5] - Tesla's stock surged by 8.2%, marking its best single-day performance since April 25 [5] Group 3 - The Chinese government initiated a special rectification campaign in the government procurement sector, targeting four types of illegal activities from June 2023 to January 2024 [6] - The State Council of China published regulations for internet platform companies regarding tax information reporting, aimed at improving tax service and management efficiency [7] - A draft amendment to the Anti-Unfair Competition Law is set for a second review, focusing on addressing "involution" competition [8] Group 4 - The Summer Davos Forum is set to open in Tianjin, with a significant increase in inbound and outbound passenger flow at the Tianjin airport [14] - Hangzhou introduced a policy allowing employees to use housing provident funds directly for down payments on new homes, easing financial pressure [15] - Chongqing released new regulations for takeout services, requiring real-time display of food processing processes for businesses without dine-in options [16] Group 5 - The U.S. Supreme Court allowed the Trump administration to resume expedited deportation procedures for immigrants [17] - The White House confirmed that Iran's nuclear facilities have been completely destroyed, reinforcing the justification for military actions taken [18] - The U.S. Embassy in Qatar advised American citizens to shelter in place due to ongoing regional tensions [20] Group 6 - Iranian domestic and international flights will be suspended until June 24, 14:00 [21] - Russian President Putin expressed willingness to assist Iran amid escalating tensions in the Middle East [22] - Japan's Prime Minister canceled his trip to the NATO summit due to the ongoing tensions following U.S. military actions in Iran [23] Group 7 - Alibaba Group announced the merger of Ele.me and Fliggy into its China e-commerce business group, marking a strategic upgrade towards becoming a comprehensive consumer platform [25] - Institutions sold 14 stocks while buying into Microchip Technology, which saw a net purchase of 86.74 million yuan [26][27]

Market Overview - On June 23, the Shanghai Composite Index rose by 0.65%, with institutional investors appearing on the trading list for 19 stocks, net buying 11 and net selling 8 [1][5]. Institutional Trading Activity - The stock with the highest net buying from institutional seats was Microchip Technology, which closed up by 15.64% with a turnover rate of 7.41% and a transaction volume of 703 million yuan. Institutional net buying amounted to 86.74 million yuan [2][6]. - Another notable stock, ShenZhou Cell, saw a closing increase of 16.66% and a turnover rate of 1.88%, with institutional net buying totaling 46.02 million yuan [2][6]. - HaiKe New Source closed up by 13.44% with a high turnover rate of 61.77%, but experienced a net outflow of 75.88 million yuan despite institutional net buying of 39.31 million yuan [3][6]. Stocks with Significant Institutional Activity - The average increase for stocks with institutional net buying was 8.86%, outperforming the Shanghai Composite Index. HaiXin Energy and Dawei Shares were among the strong performers, closing at the daily limit [3]. - Among the stocks with the highest net selling, RongZhi RiXin had a significant drop of 15.47%, with institutional net selling reaching 66.59 million yuan [3][7]. Deep and Shanghai Stock Connect - On June 23, 11 stocks on the trading list featured Deep and Shanghai Stock Connect, with net buying amounts of 85.91 million yuan for JinLongYu, 51.99 million yuan for RongFa Nuclear Power, and 42.05 million yuan for BoChang Optoelectronics [8][10]. - Notable net selling included Nord Shares and Dongxin Peace, with net selling amounts of 19.45 million yuan and 0.85 million yuan respectively [8][10].

资金流向方面，该股今日全天主力资金净流入4505.86万元。（数据宝） 神州细胞6月23日龙虎榜 | 买入营业部名称 | 买入金额(万元) | | --- | --- | | 沪股通专用 | 3966.35 | | 机构专用 | 2025.97 | | 机构专用 | 1354.46 | | 机构专用 | 1221.25 | | 瑞银证券有限责任公司上海浦东新区花园石桥路第二证券营业部 | 1181.37 | | 卖出营业部名称 | 卖出金额(万元) | | 沪股通专用 | 2570.92 | | 中国银河证券股份有限公司重庆渝中证券营业部 | 1319.13 | | 中信证券股份有限公司上海分公司 | 1228.00 | | 中国国际金融股份有限公司上海分公司 | 1124.21 | | 瑞银证券有限责任公司上海浦东新区花园石桥路第二证券营业部 | 924.14 | 6月23日神州细胞(688520)收盘价52.67元，收盘上涨16.66%，全天换手率1.88%，振幅17.86%，成交额 4.13亿元。科创板交易公开信息显示，当日该股因日收盘价涨幅达15%等上榜。 证券时报·数据宝统计显示，上榜的前五大买卖营 ...

Market Overview - On June 23, the A-share market saw all three major indices rise, with a total trading volume of 1,146.922 billion yuan, an increase of over 55 billion yuan compared to the previous Friday [1] - A total of 84 stocks hit the daily limit up [1] Concept Sectors - The military equipment restructuring concept led the gains, with stocks like Hunan Tianyan and Changcheng Military Industry hitting the limit up [1] - Other notable sectors included electronic ID cards, digital currency, and cross-border payments, which also saw significant increases [1] Institutional Trading - According to statistics, institutional seats on the Dragon and Tiger list had a net buying of 54 million yuan on June 23, with 11 stocks being net bought and 8 stocks being net sold [1] - The stocks with the highest net buying included Microchip Biotech, Shenzhou Cell, and Haike New Source, with net buying amounts accounting for 12.34%, 11.15%, and 3.11% of the day's trading volume, respectively [1][2] - The stocks with the highest net selling included Rongzhi Rixin, Youyou Food, and Beifang Changlong, with net selling amounts accounting for 29.30%, 19.05%, and 2.52% of the day's trading volume, respectively [1][2] Northbound Capital - On June 23, nine stocks received net buying from northbound funds, with Jinlongyu leading at 85.9124 million yuan [3] - Other stocks with significant net buying included Rongfa Nuclear Power and Boshang Optoelectronics, both exceeding 40 million yuan [3] Institutional Ratings - A total of 15 stocks received buy ratings from institutions, with an average increase of 1.75% for these stocks, outperforming the Shanghai Composite Index [5] - The computer industry was the most favored, with three stocks making it to the institutional buy rating list, while the coal and electric equipment industries also saw two stocks each on the list [5] Corporate Announcements - Tianyi Ma plans to acquire 100% equity of a target company specializing in IoT smart hardware and SaaS cloud platform solutions through a combination of stock issuance and cash payment [8] - Zhongda An is planning a stock issuance to specific investors, which may lead to a change in the actual controller of the company [8] - Guotou Zhonglu is planning a major asset restructuring involving the acquisition of shares from China Electronics Engineering Design Institute [8] - Huasheng Co. is planning to acquire 100% of Shenzhen Yixin Technology Co., which operates multiple high-performance computing centers [9]

Meeting Overview - The shareholders' meeting of Beijing Shenzhou Cell Biotechnology Group Co., Ltd. was held on June 23, 2025, at the company's research building in Beijing Economic and Technological Development Zone [1]. - A total of 143 ordinary shareholders attended the meeting, holding 354,393,180 voting rights, which accounted for 79.5788% of the company's total voting rights [1]. Voting Results - All proposed resolutions were approved during the meeting, with significant support from ordinary shareholders. For instance, one resolution received 98.4746% approval from ordinary shareholders [2][3]. - The voting results showed that the majority of votes were in favor, with a minimal percentage of dissenting votes and abstentions across various resolutions [2][3]. Legal Compliance - The meeting was convened in accordance with the Company Law and the company's articles of association, with the chairman Dr. Xie Liangzhi presiding over the meeting [1]. - The legal representatives confirmed that the meeting's procedures and voting results were compliant with relevant laws and regulations, ensuring the legitimacy of the proceedings [5][6].

北京市金杜律师事务所 关于北京神州细胞生物技术集团股份公司 2025 年第一次临时股东会的法律意见书 致：北京神州细胞生物技术集团股份公司 北京市金杜律师事务所（以下简称本所）接受北京神州细胞生物技术集团股 份公司（以下简称公司）的委托，根据《中华人民共和国证券法》（以下简称《证 券法》）、《中华人民共和国公司法》（以下简称《公司法》）、中国证券监督 管理委员会（以下简称中国证监会）《上市公司股东会规则（2025 修订）》（以 下简称《股东会规则》）等中华人民共和国境内（以下简称中国境内，为本法律 意见书之目的，不包括中国香港特别行政区、中国澳门特别行政区和中国台湾省） 现行有效的法律、行政法规、部门规章、规范性文件和现行有效的《北京神州细 胞生物技术集团股份公司章程》（以下简称《公司章程》）的规定，指派律师出 席了公司于 2025 年 6 月 23 日召开的 2025 年第一次临时股东会（以下简称本次 股东会），并就本次股东会相关事项出具本法律意见书。 为出具本法律意见书，本所律师审查了公司提供的以下文件，包括但不限于： 1. 经公司 2024 年年度股东大会审议通过的现行有效的《公司章程》； 2. 公司 ...